Clinical Trials - THE RIDGEWOOD BLOG.

the staff of the Ridgewood blog

Ridgewood NJ, according to Johns Hopkins Center for Health Security, as more data become available from Phase 3 clinical vaccine trials, it is natural to compare vaccines’ performance characteristics against each other. For example, the Mayor of Detroit, Michigan, reportedly declined a shipment of the J&J-Janssen vaccine in favor of prioritizing the Pfizer-BioNTech and Moderna vaccines. But unlike many products that have well-established standards and metrics, the clinical trials for each vaccine were designed and implemented independently, which makes direct comparison difficult. The focus on specific efficacy numbers between trials may not provide the whole picture. The relatively small numbers of severe cases and deaths in the clinical trials for all of the vaccines so far make it more difficult to evaluate their efficacy in preventing more severe forms of COVID-19, as a single case could result in major changes to the efficacy estimates.

Continue reading Comparing Vaccines, Experts say , “The best vaccine is the one that’s in your arm”

Clinical Contributors to this Story Ihor Sawczuk, M.D. contributes to topics such as Medical Research, Urology.

Hackensack NJ, The United States has begun to roll out COVID-19 vaccines in an effort to help stop the pandemic. Millions of people will line up across the country to get the vaccine, expected to be approved by the U.S. government.

For many, we’ve never really thought about the approval process that every vaccine, including the COVID-19 vaccine, must go through before getting approved for public use. It’s an extensive and rigorous process to ensure it’s safe before it can be distributed to the community.

Continue reading Hackensack Meridian Health : Behind the COVID-19 Vaccine Approval Process